
Conference Coverage
Latest Content

HERIZON-GEA-01 Results Indicate Potential 1L Use of Zanidatamab for Gastroesophageal Adenocarcinoma

Outdoor Artificial Light May Extend Light Sleep While Altering Deep Sleep Patterns

USDA and HHS Update Dietary Guidelines to Encourage Real Food, Less Sugar

CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making

β-Blockers Show No Added Benefit After MI With Preserved LVEF
Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Patients with myasthenia gravis experience significantly higher rates of urinary incontinence and overactive bladder symptoms, impacting their quality of life.

Telehealth Intervention by Pharmacists Collaboratively Enhances Hypertension Management and Outcomes
Patient interaction and enhanced support with clinical pharmacists significantly improved pass rates for a measure of controlling blood pressure compared with usual care.

These results were presented during the press briefing ahead of the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium.

Nimbus Therapeutics and Eli Lilly announce their partnership to develop a novel oral drug for patients with obesity and other metabolic disorders.

Food insecurity is associated with a lower rate of annual visits but a higher share of telehealth visits for primary and preventive care.

Telemedicine use in rural areas was associated with a higher likelihood of utilizing preventive services.

The CDC announced a significant change to the childhood immunization schedule that would reduce vaccine recommendations.

Economic stability and social factors significantly influence the risk of pediatric long COVID, highlighting the need for targeted health interventions.

The treatment was compared with adagrasib in second- and subsequent-line treatment, with sotarasib coming out on top based on current efficacy data.

A study shows falling CRLM incidence and improved survival for synchronous disease, with persistent gaps for metachronous metastases.










































































